FDA grants orphan status to two Lux products

March 1, 2007

Article

The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

An older woman with glasses on sits and reads a book, a mug of coffee in front of her. Concept image for geographic atrophy lesions (GA) and age-related macular degeneration (AMD). Image credit: ©MiguelAngel – stock.adobe.com

Progression rates vary in subtypes of geographic atrophy lesions

Lynda Charters

August 28th 2025

Article

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD

August 28th 2025

Podcast

The Eiffel Tower/La Tour Eiffel, as viewed from under a bridge in Paris, France. Concept image for EURETINA 25th anniversary and retina specialist meeting conference in Europe. Image credit: ©Dario – stock.adobe.com

What to expect at this year's European Society of Retina Specialists (EURETINA) Congress

Hattie Hayes

August 28th 2025

Article

$Concept image for the balancing of energy efficiency and time in refractive surgery phacoemulsification. A scale, with a laser beam of blue light on one side, and an analog alarm clock on the other side. The laser beam of blue light is surrounded by static. Created with Canva Magic AI.$